Lack of ecto-5′-nucleotidase (CD73) promotes arteriogenesis

Cardiovascular Research

Volumn 97, Issue 1, 2013, Pages 88-96

  Böring, Yang Chul ^a,c   Flögel, Ulrich ^a   Jacoby, Christoph ^a   Heil, Matthias ^b   Schaper, Wolfgang ^b   Schrader, Jürgen ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Adenosine; Arteriogenesis; CD73; MR spectroscopy; MRI

Indexed keywords

ADENOSINE; ECTO 5' NUCLEOTIDASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL ADHESION; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM; HIGH ENERGY PHOSPHATE; LIMB ISCHEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MONOCYTE; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; WILD TYPE;

5'-NUCLEOTIDASE; ADENOSINE; ANIMALS; ARTERIES; CAPILLARIES; COLLATERAL CIRCULATION; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GPI-LINKED PROTEINS; HINDLIMB; ISCHEMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; RECOVERY OF FUNCTION; REGIONAL BLOOD FLOW; TIME FACTORS;

EID: 84871784120     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs286     Document Type: Article

References (57)

1. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardio-vasc Res 2001;49:543-553. (Pubitemid 32146417)
2. Pipp F, Boehm S, Cai WJ, Adili F, Ziegler B, Karanovic G et al. Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler Thromb Vasc Biol 2004;24:1664-1668. (Pubitemid 39180892)
3. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998;101:40-50. (Pubitemid 28058901)
4. Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M et al. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol 2002;283:H2411-H2419. (Pubitemid 35345945)
5. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 2001;104:2012-2017. (Pubitemid 33027039)
6. Voskuil M, van Royen N, Hoefer IE, Seidler R, Guth BD, Bode C et al. Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am J Physiol Heart Circ Physiol 2003;284:H1422-H1428. (Pubitemid 36348606)
7. Hoefer IE, van Royen N, Rectenwald JE, Bray EJ, Abouhamze Z, Moldawer LL et al. Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation 2002;105:1639-1641. (Pubitemid 34298605)
8. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003;9:604-613. (Pubitemid 36597108)
9. Meininger CJ, Schelling ME, Granger HJ. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol 1988;255:H554-H562.
10. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50:413-492. (Pubitemid 28477681)
11. Xu MH, Gong YS, Su MS, Dai ZY, Dai SS, Bao SZ et al. Absence of the adenosine A(2A) receptor confers pulmonary arterial hypertension and increased pulmonary vascular remodeling in mice. J Vasc Res 2011;48:171-183.
12. Ngamsri KC, Wagner R, Vollmer I, Stark S, Reutershan J. Adenosine receptor A1 regulates polymorphonuclear cell trafficking and microvascular permeability in lipopolysaccharide-induced lung injury. J Immunol 2010;185:4374-4384.
13. Romio M, Reinbeck B, Bongardt S, Hüls S, Burghoff S, Schrader J. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells. Am J Physiol Cell Physiol 2011;301:C530-C539.
14. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001; 97:587-600. (Pubitemid 32113390)
15. Kunapuli SP, Daniel JL. P2 receptor subtypes in the cardiovascular system. Biochem J 1998;336(Pt 3):513-523.
16. ′-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ Res 2004;95:814-821. (Pubitemid 39390584)
17. 2/2 knockout mice revascu-larize normally in response to severe hindlimb ischemia. J Vasc Surg 2004;40:786-795. (Pubitemid 39311648)
18. Jacoby C, Boring YC, Beck A, Zernecke A, Aurich V, Weber C et al. Dynamic changes in murine vessel geometry assessed by high-resolution magnetic resonance angiog-raphy: a 9.4T study. J Magn Reson Imaging 2008;28:637-645.
19. Heil M, Ziegelhoeffer T, Wagner S, Fernandez B, Helisch A, Martin S et al. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res 2004;94:671-677. (Pubitemid 38387751)
20. Scholz D, Ziegelhoeffer T, Helisch A, Wagner S, Friedrich C, Podzuweit T et al. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol 2002;34:775-787. (Pubitemid 35205180)
21. Helisch A, Wagner S, Khan N, Drinane M, Wolfram S, Heil M et al. Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler Thromb Vasc Biol 2006;26:520-526.
22. Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER. Activated macrophages induce vascular proliferation. Nature 1977;269:804-806. (Pubitemid 8208827)
23. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6:389-395. (Pubitemid 30208155)
24. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674. (Pubitemid 27193480)
25. Asperio RM, Nicolato E, Marzola P, Farace P, Lunati E, Sbarbati A et al. Delayed muscle injuries in arterial insufficiency: contrast-enhanced MR imaging and 31P spec-troscopy in rats. Radiology 2001;220:413-419. (Pubitemid 32667178)
26. Giannesini B, Izquierdo M, Le Fur Y, Cozzone PJ, Fingerle J, Himber J et al. New experimental setup for studying strictly noninvasively skeletal muscle function in rat using 1H-magnetic resonance (MR) imaging and 31P-MR spectroscopy. Magn Reson Med 2005;54:1058-1064. (Pubitemid 41567182)
27. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. Mouse model of angiogenesis. Am J Pathol 1998;152:1667-1679. (Pubitemid 28275025)
28. Herzog S, Sager H, Khmelevski E, Deylig A, Ito WD. Collateral arteries grow from preexisting anastomoses in the rat hindlimb. Am J Physiol Heart Circ Physiol 2002; 283:H2012-H2020. (Pubitemid 35217036)
29. Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ Res 1996;79:911-919. (Pubitemid 26359232)
30. Bergmann CE, Hoefer IE, Meder B, Roth H, van Royen N, Breit SM et al. Arteriogen-esis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J Leukoc Biol 2006;80:59-65. (Pubitemid 44835526)
31. Buschmann I, Heil M, Jost M, Schaper W. Influence of inflammatory cytokines on arteriogenesis. Microcirculation 2003;10:371-379. (Pubitemid 39004263)
32. Persson AB, Buschmann IR. Vascular growth in health and disease. Front Mol Neurosci 2011;4:14.
33. de Groot D, Hoefer IE, Grundmann S, Schoneveld A, Haverslag RT, van Keulen JK et al. Arteriogenesis requires toll-like receptor 2 and 4 expression in bone-marrow derived cells. J Mol Cell Cardiol 2011;50:25-32.
34. Monaco C. Innate immunity meets arteriogenesis: the versatility of toll-like receptors. J Mol Cell Cardiol 2010;50:9-12.
35. Takeda Y, Costa S, Delamarre E, Roncal C, Leite de Oliveira R, Squadrito ML et al. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arter-iogenesis. Nature 2011;479:122-126.
36. Blackburn MR, Vance CO, Morschl E, Wilson CN. Adenosine receptors and inflammation. Handb Exp Pharmacol 2009;193:215-269.
37. ′-nucleotidase protects against vascular inflammation and neoin-tima formation. Circulation 2006;113:2120-2127.
38. ′-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 2004;200:1395-1405. (Pubitemid 39657287)
39. Bouma MG, van den Wildenberg FA, Buurman WA. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol 1996;270:C522-C529.
40. Sullivan GW, Lee DD, Ross WG, DiVietro JA, Lappas CM, Lawrence MB et al. Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils. J Leukoc Biol 2004; 75:127-134. (Pubitemid 38166787)
41. Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP. Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junc-tional permeability. FASEB J 2002;16:583-585.
42. Srinivas SP, Satpathy M, Gallagher P, Lariviere E, Van Driessche W. Adenosine induces dephosphorylation of myosin II regulatory light chain in cultured bovine corneal endo-thelial cells. Exp Eye Res 2004;79:543-551. (Pubitemid 39232116)
43. Kreckler LM, Wan TC, Ge ZD, Auchampach JA. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J Pharmacol Exp Ther 2006;317:172-180.
44. ′-nucleotidase/CD73-dependent mechanism. J Biol Chem 2003;278:24888-24895. (Pubitemid 37548648)
45. ′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med 1998;188:1433.
46. Grunewald JK, Ridley AJ. CD73 represses pro-inflammatory responses in human endothelial cells. J Inflamm (Lond) 2010;7:10.
47. Linden J, Cekic C. Regulation of lymphocyte function by adenosine. Arterioscler Thromb Vasc Biol 2012;32:2097-2103.
48. Cronstein BN, Levin RI, Belanoff J, Weissmann G, Hirschhorn R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 1986;78:760-770. (Pubitemid 16024813)
49. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-964. (Pubitemid 41746764)
50. Csóka B, Németh ZH, Virág L, Gergely P, Leibovich SJ, Pacher P et al. A2A adenosine receptors and C/EBPb are crucially required for IL-10 production by macrophages exposed to Escherichia coli. Blood 2007;110:2685-2695. (Pubitemid 47523193)
51. Németh ZH, Lutz CS, Csóka B, Deitch EA, Leibovich SJ, Gause WC et al. Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated post-transcriptional mechanism. J Immunol 2005;175:8260-8270. (Pubitemid 41798391)
52. Csóka B, Selmeczy Z, Koscsó B, Németh ZH, Pacher P, Murray PJ et al. Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J 2012;26:376-386.
53. Adair TH. Growth regulation of the vascular system: an emerging role for adenosine. Am J Physiol Reg Integr Comp Physiol 2005;289:R283-R296. (Pubitemid 41060476)
54. Ethier MF, Chander V, Dobson JG Jr. Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol 1993;265:H131-H138. (Pubitemid 23224700)
55. Clark AN, Youkey R, Liu X, Jia L, Blatt R, Day Y-J et al. A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Circ Res 2007; 101:1130-1138. (Pubitemid 350146439)
56. Deindl E, Hoefer IE, Fernandez B, Barancik M, Heil M, Strniskova M et al. Involvement of the fibroblast growth factor system in adaptive and chemokine-induced arteriogen-esis. Circ Res 2003;92:561-568. (Pubitemid 36368670)
57. St Hilaire C, Ziegler SG, Markello TC, Brusco A, Groden C, Gill F et al. NT5E mutations and arterial calcifications. N Eng J Med 2011;364:432-442.